Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases(2025 edition)
10.7659/j.issn.1005-6947.250402
- VernacularTitle:结直肠癌肝转移诊断和综合治疗指南(2025版)
- Collective Name:Chinese Society of Surgeons,Chinese Medical Doctor Association;Gastrointestinal Surgery Group,Chinese Society of Surgery,Chinese Medical Association;Colorectal Surgery Group,Chinese Society of Surgery,Chinese Medical Association;Colorectal Cancer Committee,Chinese Anti-Cancer Association;Colorectal Oncology Committee,Chinese Medical Doctor Association;Expert Committee on Colorectal Cancer,Chinese Society of Clinical Oncology;Colorectal Surgery Committee,Chinese Society of Surgeons,Chinese Medical Doctor Association;Tumor Metastasis Committee,Coloproctology Society,Chinese Medical Doctor Association;Colorectal Oncology Group,Chinese Society of Oncology,Chinese Medical Association;Division of Metastatic Tumor Therapy,China International Exchange and Promotive Association for Medical and Health Care;Division of Colorectal Diseases,China International Exchange and Promotive Association for Medical and Health Care
- Publication Type:Journal Article
- Keywords:
Colorectal Neoplasms;
Neoplasm Metastasis;
Practice Guideline
- From:
Chinese Journal of General Surgery
2025;34(8):1565-1588
- CountryChina
- Language:Chinese
-
Abstract:
To further standardize and improve the management of colorectal liver metastases(CRLM)in China,the Chinese guidelines for the diagnosis and comprehensive treatment of colorectal cancer liver metastases(2025 edition)have been systematically updated based on previous versions and the latest international and domestic evidence.The updated guideline refines diagnostic pathways,strengthens multidisciplinary team collaboration,and comprehensively upgrades therapeutic strategies-including surgical resection,neoadjuvant and adjuvant treatments for patients eligible for no evidence of disease(NED)status,and systemic therapy for those who are not.It also expands the scope of genetic testing,incorporates innovative local ablative therapies,and emphasizes standardized follow-up and long-term management.The guideline aims to promote individualized and precision-based treatment,ultimately improving clinical outcomes and patient survival.It serves as a practical,evidence-based reference for healthcare providers managing CRLM across China.
